Table 1.
MS (n = 23) | Non-MS (n = 18) | p | |
---|---|---|---|
Mean age (range, yr) | 56 (25-77) | 66 (36-89) | NS |
M:F | 11:12 | 9:9 | NS |
Disease phenotype | PP-MS (n = 5) RR-MS (n = 4) SP-MS (n = 14) |
Non-CNS disease (cancer, sepsis, myocardial infarction, drug overdose (n = 12), amyotrophic lateral sclerosis (n = 3), stroke (n = 3), multisystem atrophy (n = 1) | |
EDSS | 4.0-9.5 | NA |
aMean age, sex, disease phenotype, and Expanded Disability Status Scale (EDSS) of MS (n = 23) and non-MS (n = 18) used in the present study. MS patients include primary progressive MS (PP-MS, n = 5), relapsing-remitting MS (RR-MS, n = 4), and secondary progressive MS (SP-MS, n = 14). Mann–Whitney U test was used to assess significant difference in age between MS and non-MS, and Fisher's exact test was used to assess significant difference in sex between groups.